Contrast-enhanced ultrasound for molecular imaging of angiogenesis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue SUPPL. 1, 2010, Pages

  Eisenbrey, J R ^a   Forsberg, F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Contrast agent; Microbubbles; Ultrasound

Indexed keywords

1,2 DIBEHENOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [BIOTINYL(POLYETHYLENE GLYCOL)2000]; AFLIBERCEPT; ARGINYLGLYCYLASPARTIC ACID; BEVACIZUMAB; CELL MARKER; CONTRAST MEDIUM; CYANOACRYLATE; DOXORUBICIN; ECHISTATIN; FIBRINOLYTIC AGENT; FIBROBLAST GROWTH FACTOR 2; INTEGRIN; MACROGOL STEARATE; MATRIGEL; POLYLACTIC ACID; SUNITINIB; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; COLON ADENOCARCINOMA; CONTRAST ENHANCEMENT; DISEASE FREE SURVIVAL; DOPPLER FLOWMETRY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIMB ISCHEMIA; LIVER CELL CARCINOMA; MAXIMUM INTENSITY PROJECTION; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; OVERALL SURVIVAL; PARAMETER; REVIEW; SIGNAL NOISE RATIO; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; ULTRASOUND;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; ULTRASONOGRAPHY;

EID: 77956267898     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1449-6     Document Type: Review

References (62)

1. N Makrilia T Lappa V Xyla I Nikolaidis K Syrigos 2009 The role of angiogenesis in solid tumours: an overview Eur J Intern Med 20 663 671 10.1016/j.ejim.2009.07.009 1:CAS:528:DC%2BD1MXht1CqurvJ 19818284
2. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound contrast agents: basic principles and clinical applications. 2nd ed. London: Martin Dunitz; 2001.
3. F Forsberg AP Dicker ML Thakur NM Rawool JB Liu WT Shi, et al. 2002 Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results Ultrasound Med Biol 28 445 451 10.1016/S0301-5629(02)00482-9 12049957
4. F Forsberg B Kuruvilla MB Pascua MH Chaudhari DA Merton JP Palazzo, et al. 2008 Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity Ultrasound Med Biol 34 1365 1372 10.1016/j.ultrasmedbio.2008.02.010 18436369
5. Ro RJ, Forsberg F, Liu JB, Fox TB, Potoczek M, Chiou SY, Lewin PA, Goldberg BB. Assessing angiogenesis in murine glioma and breast tumor models with contrast-enhanced ultrasound imaging. Proc IEEE US Symp 2006:416-19.
6. AC Fleicher 2000 Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications J Ultrasound Med 19 55 61
7. RJ Schroeder P Hauff T Bartels K Vogel J Jeschke N Hidajat, et al. 2001 Tumor vascularization in experimental melanomas: correlation between unenhanced and contrast enhanced power Doppler imaging and histological grading Ultrasound Med Biol 27 761 771 10.1016/S0301-5629(01)00363-5 1:STN:280: DC%2BD3MvntVeitg%3D%3D 11516536
8. RA Linden EJ Trabulsi F Forsberg PR Gittens LJ Gomella EJ Halpern 2007 Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies J Urol 178 2354 2358 10.1016/j.juro.2007.08.022 17936814
9. K Sugimoto F Moriyasu N Kamiyama R Metoki M Yamada Y Imai, et al. 2008 Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast-enhanced sonography Hepatol Res 38 790 799 10.1111/j.1872-034X.2008.00331.x 18507694
10. SR Wilson HJ Jang TK Kim H Iijima N Kamiyama PN Burns 2008 Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography AJR Am J Roentgenol 190 3 691 695 10.2214/AJR.07.3116 18287440
11. I Iordanescu C Becker B Zetter P Dunning GA Taylor 2002 Tumor vascularity: evaluation in a murine model with contrast-enhanced color Doppler US-effect of angiogenesis inhibitors Radiology 222 460 467 10.1148/radiol. 2222010660 11818614
12. M Krix F Kiessling S Vosseler I Kiessling M Le-Huu NE Fusenig, et al. 2003 Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumor perfusion in small animals Ultrasound Med Biol 29 1093 1103 10.1016/S0301-5629(03)00060-7 12946512
13. KJ Niermann AC Fleischer J Huamani TE Yankeelov DW Kim WD Wilson, et al. 2007 Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography J Ultrasound Med 26 749 756 17526606
14. RE Pollard AR Broumas ER Wisner SV Vekich KW Ferrara 2007 Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats Ultrasound Med Biol 33 235 245 10.1016/j.ultrasmedbio.2006.07.036 17306694
15. Ro RJ, Forsberg F, Liu JB, Chiou SY, Merton DA, Lipcan KJ, Potoczek M, Dicker AP, Nazarian LN. Contrast enhanced US for monitoring the effect of VEGF Trap on melanoma tumor vascularity. Proc IEEE Ultrason Symp, 1977-1980, 2007.
16. A Guibal L Taillade S Mulé E Comperat Y Badachia JL Golmard, et al. 2010 Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy Radiology 254 420 429 10.1148/radiol.09090728 20093514
17. PV Dickson JB Hamner TL Sims CH Fraga CY Ng S Rajasekeran, et al. 2007 Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy Clin Cancer Res 13 3942 3950 10.1158/1078-0432.CCR-07- 0278 1:CAS:528:DC%2BD2sXntFymt7o%3D 17606728
18. F Forsberg R Ro M Potoczek JB Liu KM James AP Dicker, et al. 2004 Assessment of angiogenesis: implications for ultrasound imaging Ultrasonics 42 325 330 10.1016/j.ultras.2003.12.026 1:CAS:528:DC%2BD2cXislWjurg%3D 15047306
19. N Lassau S Koscielny L Albiges L Chami B Benatsou M Chebil, et al. 2010 Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography Clin Cancer Res 16 1216 1225 10.1158/1078-0432.CCR-09-2175 1:CAS:528:DC%2BC3cXhvFGiurg%3D 20145174
20. M Averkiou M Lampaskis K Kyriakopoulou D Skarlos G Klouvas C Strouthos, et al. 2010 Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy Ultrasound Med Biol 36 68 77 10.1016/j.ultrasmedbio.2009.07.005 19900749
21. Cosgrove DO, Lassua N. Ultrasound perfusion imaging of angiogenesis. Eur J Nucl Med Mol Imaging 2010; In press.
22. J Du FH Li H Fang JG Xia CX Zhu 2008 Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions J Ultrasound Med 27 821 831 18499842
23. S Huber M Vesely I Zuna S Delorme H Czembirek 2001 Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology Ultrasound Med Biol 27 3 11 10.1016/S0301-5629(00)00282-9 1:STN:280:DC%2BD3Mvit12muw%3D%3D 11295265
24. WT Yang GMK Tse PKW Lam C Metreweli J Chang 2002 Correlation between color power Doppler sonographic measurement of tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis J Ultrasound Med 21 1227 1235 1:CAS:528:DC%2BD38Xls1amsL8%3D 12418764
25. H Leong-Poi 2009 Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy Cardiovasc Res 84 190 200 10.1093/cvr/cvp248 1:CAS:528:DC%2BD1MXht1OrtLrE 19628466
26. FS Villanueva WR Wagner 2008 Ultrasound molecular imaging of cardiovascular disease Nat Clin Pract Cardiovasc Med 5 S26 S32 10.1038/ncpcardio1246 1:CAS:528:DC%2BD1cXoslensbc%3D 18641604
27. D Coppolino S Dedhar 2000 Bi-directional signal transduction by integrin receptors Int J Biochem Cell Biol 32 171 188 10.1016/S1357-2725(99)00043-6 1:CAS:528:DyaK1MXnvFeis7s%3D 10687952
28. PC Brooks RA Clark DA Cheresh 1994 Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 569 571 10.1126/science.7512751 1:CAS:528:DyaK2cXjt1Sis7w%3D 7512751
29. PA Dayton D Pearson J Clark S Simon PA Schumann R Zutshi, et al. 2004 Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells Mol Imaging 3 125 134 10.1162/1535350041464883 1:CAS:528:DC%2BD2cXlvFCiu7k%3D 15296677
30. MA Wheatley JD Lathia KL Oum 2007 Polymeric ultrasound contrast agent targeted to integrins: importance of process methods and surface density of ligands Biomacromolecules 8 516 522 10.1021/bm060659i 1:CAS:528: DC%2BD28XhtlCit7zN 17291076
31. H Leong-Poi J Christiansen AL Klibanov S Kaul JR Lindner 2003 Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins Circulation 107 455 460 10.1161/01.CIR.0000044916.05919.8B 1:CAS:528:DC%2BD3sXks1eksQ%3D%3D 12551871
32. GER Weller MKK Wong RA Modzelewski E Lu A Klibanov WR Wagner, et al. 2005 Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine Cancer Res 65 533 539 1:CAS:528:DC%2BD2MXns1Kquw%3D%3D 15695396
33. JK Willmann RH Kimura N Deshpande AM Lutz JR Cochran SS Gambhir 2010 Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides J Nucl Med 51 433 440 10.2967/jnumed.109.068007 1:CAS:528:DC%2BC3cXksVylsrw%3D 20150258
34. JD Lathia L Leodore MA Wheatley 2004 Polymeric contrast agent with targeting potential Ultrasonics 42 763 768 10.1016/j.ultras.2003.12.018 1:CAS:528:DC%2BD2cXislWisL8%3D 15047380
35. H Leong-Poi J Christiansen P Heppner CW Lewis AL Klibanov S Kaul, et al. 2005 Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression Circulation 111 3248 3254 10.1161/CIRCULATIONAHA.104.481515 1:CAS:528:DC%2BD2MXltVKmtr4%3D 15956135
36. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 257 10.1038/35025220 1:CAS:528:DC%2BD3cXmvVSls74%3D 11001068
37. L Brannon-Peppas JO Blanchette 2004 Nanoparticle and targeted systems for cancer therapy Adv Drug Deliv Rev 56 1649 1659 10.1016/j.addr.2004.02.014 1:CAS:528:DC%2BD2cXntlGltro%3D 15350294
38. A Lyshchik AC Fleisher J Huamani DE Hallahan M Brissova JC Gore 2007 Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography J Ultrasound Med 26 1575 1586 17957052
39. G Korpanty JG Carbon PA Grayburn JB Fleming RA Brekken 2007 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin Cancer Res 13 323 330 10.1158/1078-0432.CCR-06-1313 1:CAS:528: DC%2BD2sXotlag 17200371
40. JK Willmann AM Lutz R Paulmurugan MR Patel P Chu J Rosenberg, et al. 2008 Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo Radiology 248 936 944 10.1148/radiol.2483072231 18710985
41. JJ Rychak J Graba AM Cheung BS Mystry JR Lindner RS Kerbel, et al. 2007 Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis Mol Imaging 6 289 296 18092513
42. M Palmowski J Huppert G Ladewig P Hauff M Reinhardt MM Mueller, et al. 2008 Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects Mol Cancer Ther 7 101 109 10.1158/1535-7163.MCT-07-0409 1:CAS:528:DC%2BD1cXmsVyhsw%3D%3D 18202013
43. H Okahara H Yagita K Miyake K Okumura 1994 Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis Cancer Res 54 3233 3236 1:CAS:528:DyaK2cXktlaqsLo%3D 7515767
44. G Molema LFMH de Leij DKF Meijer 1997 Tumor vascular endothelium: barrier or target in tumor directed drug delivery and immunotherapy Pharm Res 14 2 10 10.1023/A:1012038930172 1:CAS:528:DyaK2sXhsFWrt7o%3D 9034214
45. CZ Behm BA Kaufmann C Carr M Lankford JM Sanders CE Rose, et al. 2008 Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis Circulation 117 2902 2911 10.1161/CIRCULATIONAHA.107.744037 1:CAS:528:DC%2BD1cXmsVOjs7Y%3D 18506006
46. AJ Hamilton SL Huang D Warnick M Rabbat B Kane A Nagaraj, et al. 2004 Intravascular ultrasound molecular imaging of atheroma components in vivo J Am Coll Cardiol 43 453 460 10.1016/j.jacc.2003.07.048 15013130
47. AL Klibanov 1999 Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging Adv Drug Deliv Rev 37 139 157 10.1016/S0169- 409X(98)00104-5 1:CAS:528:DyaK1MXis1altL0%3D 10837732
48. R Bekeredjian HA Katus HF Kuecherer 2006 Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications Ultraschall Med 27 134 140 10.1055/s-2005-858993 1:STN:280: DC%2BD283gs1arsQ%3D%3D 16612722
49. PA Dijkmans LJM Juffermans RJP Musters A van Wamel FJ ten Cate W van Gilst, et al. 2004 Microbubbles and ultrasound: from diagnosis to therapy Eur J Echocardiogr 5 245 256 10.1016/j.euje.2004.02.001 1:STN:280: DC%2BD2czhvVGnug%3D%3D 15219539
50. S Hernot AL Klibanov 2008 Microbubbles in ultrasound-triggered drug and gene delivery Adv Drug Deliv Rev 60 1153 1166 10.1016/j.addr.2008.03.005 1:CAS:528:DC%2BD1cXmsFKrtLg%3D 18486268
51. K Ferrara R Pollard M Borden 2007 Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery Annu Rev Biomed Eng 9 415 447 10.1146/annurev.bioeng.8.061505.095852 1:CAS:528:DC%2BD2sXhtVehtLfN 17651012
52. EC Unger TP McCreery RH Sweitzer VE Caldwell Y Wu 1998 Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent Invest Radiol 33 886 892 10.1097/00004424-199812000-00007 1:CAS:528:DyaK1cXotVKnsLw%3D 9851823
53. SD Tiukinhoy-Laing S Huang M Klegerman CK Holland DD McPherson 2007 Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes Thromb Res 119 777 784 10.1016/j.thromres.2006.06.009 1:CAS:528:DC%2BD2sXjsVGis7Y%3D 16887172
54. MA Borden CH Caskey E Little RJ Gillies KW Ferrara 2007 DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles Langmuir 23 9401 9408 10.1021/la7009034 1:CAS:528: DC%2BD2sXotlCrtb0%3D 17665937
55. CM Howard F Forsberg C Minimo JB Liu DA Merton PP Claudio 2006 Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents J Cell Physiol 209 413 421 10.1002/jcp.20736 1:CAS:528:DC%2BD28XhtVClu7bE 16883597
56. S Tinkov G Winter C Coester R Bekeredjian 2010 New doxorubicin-loaded phospholipids microbubbles for targeted tumor therapy: part I-formulation development and in-vitro characterization J Control Release 143 143 150 10.1016/j.jconrel.2009.12.026 1:CAS:528:DC%2BC3cXjtFOju7k%3D 20060861
57. J Kang X Wu Z Wang H Ran C Xu J Wu, et al. 2010 Antitumor effect of docetaxel-loaded lipid microbubbles combined with ultrasound-targeted microbubble activation on VX2 rabbit liver tumors J Ultrasound Med 29 61 70 20040776
58. I Lentacker B Geers J Demeester SC De Smedt NN Sanders 2010 Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved Mol Ther 18 101 108 10.1038/mt.2009.160 1:CAS:528:DC%2BD1MXoslymtL4%3D 19623162
59. Shi WT, Böhmer MR, Emmer M et al. Ultrasound therapy with drug loaded microcapsules. Proc IEEE US Symp 2007; 773-6.
60. ZH Gao HD Fain N Rapoport 2005 Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound J Control Release 102 203 222 10.1016/j.jconrel.2004.09.021 1:CAS:528:DC%2BD2MXktVGiug%3D%3D 15653146
61. JR Eisenbrey OM Burstein R Kambhampati F Forsberg LB Liu MA Wheatley 2010 Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery J Control Release 143 38 44 10.1016/j.jconrel.2009.12.021 1:CAS:528:DC%2BC3cXjtFOisro%3D 20060024
62. JR Eisenbrey MC Soulen MA Wheatley 2010 Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents IEEE Trans Biomed Eng 57 24 28 10.1109/TBME.2009.2030497 1:STN:280:DC%2BC3c%2Fhs12hsA%3D%3D 19709952